Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fortinn Cold
- Development stage
- Unknown
- Lead developer
- INNventa Pharm
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Fortinn Cold (also marketed as Fortinn gel COLD) is a multi-ingredient topical gel developed and marketed by INNventa Pharm. It is formulated with a high concentration of active components, including thyme extract (*Thymus vulgaris*), yarrow extract (*Achillea millefolium*), menthol, camphor, methyl salicylate, panthenol, bisabolol, and a vitamin B complex (B1, B5, B6). The gel is designed to provide a cooling sensation upon application, primarily mediated by menthol acting on thermosensitive receptors in the skin. Collectively, its ingredients work synergistically to improve local blood circulation, reduce inflammation, alleviate pain and swelling, relieve muscle cramps, and increase joint mobility. It is indicated for the relief of symptoms associated with rheumatic conditions, muscle and joint pain, neck and back stiffness, and sports injuries such as sprains and strains.
- Brand names
- Fortinn ColdFortinn gel COLD
- Other names
- Fortinn gel coldFortinn® gel COLD
02
Targets
TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPV3 (Transient receptor potential vanilloid subtype 3)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Fortinn Cold.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fortinn Cold.